Amgen (AMGN) Change in Acquisitions & Divestments (2009 - 2023)
Amgen's quarterly Change in Acquisitions & Divestments came in at -$575.0 million in Q3 2023, down 1123.4% year-on-year from $56.2 million in Q3 2022, and down 57600.0% quarter-over-quarter from $1.0 million in Q2 2023.
Amgen has reported Change in Acquisitions & Divestments for 15 years, with the latest figure at -$575.0 million in Q3 2023.
- For the quarter ending Q3 2023, Change in Acquisitions & Divestments fell 1123.4% year-over-year to -$575.0 million; the trailing twelve-month figure through Jun 2024 stood at -$575.0 million (down 126.16% YoY), and the FY2023 full-year result was $550.0 million, down 50.89% from the prior year.
- Change in Acquisitions & Divestments for Q3 2023 stood at -$575.0 million, down from $1.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $18.2 billion in Q3 2019, with the low at -$9.6 billion in Q4 2019.
- Average Change in Acquisitions & Divestments over 5 years is $1.3 billion, with a median of $904.0 million recorded in 2021.
- Peak annual rise in Change in Acquisitions & Divestments reached 1959.2% in 2020, while the deepest fall reached 2639.13% in 2020.
- Tracing AMGN's Change in Acquisitions & Divestments over 5 years: stood at -$9.6 billion in 2019, then soared by 124.58% to $2.4 billion in 2020, then plunged by 61.68% to $904.0 million in 2021, then climbed by 23.89% to $1.1 billion in 2022, then plunged by 151.34% to -$575.0 million in 2023.
- The last three Change in Acquisitions & Divestments figures came in at -$575.0 million (Q3 2023), $1.0 million (Q2 2023), and $1.1 billion (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -575.00 Mn |
| Sep 30, 2023 | -575.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.12 Bn |
| Mar 31, 2023 | 1.12 Bn |
| Dec 31, 2022 | 1.12 Bn |
| Dec 31, 2022 | 1.12 Bn |
| Sep 30, 2022 | -47.00 Mn |
| Sep 30, 2022 | -47.00 Mn |
| Jun 30, 2022 | 47.00 Mn |
| Jun 30, 2022 | 47.00 Mn |
| Dec 31, 2021 | 904.00 Mn |
| Dec 31, 2021 | 904.00 Mn |
| Sep 30, 2021 | 1.40 Bn |
| Sep 30, 2021 | 1.40 Bn |
| Jun 30, 2021 | 2.53 Bn |
| Jun 30, 2021 | 2.53 Bn |
| Mar 31, 2021 | 4.00 Bn |
| Mar 31, 2021 | 4.00 Bn |
| Sep 30, 2020 | 2.36 Bn |
| Sep 30, 2020 | 2.36 Bn |
| Jun 30, 2020 | -2.34 Bn |
| Jun 30, 2020 | -2.34 Bn |
| Mar 31, 2020 | 2.57 Bn |
| Mar 31, 2020 | 2.57 Bn |
| Dec 31, 2019 | -9.60 Bn |
| Dec 31, 2019 | -9.60 Bn |
| Sep 30, 2019 | 18.22 Bn |
| Sep 30, 2019 | 18.22 Bn |
| Jun 30, 2019 | 92.00 Mn |
| Jun 30, 2019 | 92.00 Mn |
| Mar 31, 2019 | 125.00 Mn |
| Mar 31, 2019 | 125.00 Mn |
| Dec 31, 2018 | -22.65 Bn |
| Dec 31, 2018 | -22.65 Bn |
| Sep 30, 2018 | 27.07 Bn |
| Sep 30, 2018 | 27.07 Bn |
| Jun 30, 2018 | -15.70 Bn |
| Jun 30, 2018 | -15.70 Bn |
| Mar 31, 2018 | 16.69 Bn |
| Mar 31, 2018 | 16.69 Bn |
| Dec 31, 2017 | -12.41 Bn |
| Dec 31, 2017 | -12.41 Bn |
| Sep 30, 2017 | 15.30 Bn |
| Sep 30, 2017 | 15.30 Bn |
| Jun 30, 2017 | 1.76 Bn |
| Jun 30, 2017 | 1.76 Bn |
| Mar 31, 2017 | 1.53 Bn |
| Mar 31, 2017 | 1.53 Bn |
| Dec 31, 2016 | -11.61 Bn |
| Dec 31, 2016 | -11.61 Bn |
| Sep 30, 2016 | 5.01 Bn |
| Sep 30, 2016 | 5.01 Bn |
| Jun 30, 2016 | 8.61 Bn |
| Jun 30, 2016 | 8.61 Bn |
| Mar 31, 2016 | 458.00 Mn |
| Mar 31, 2016 | 458.00 Mn |
| Dec 31, 2015 | 6.25 Bn |
| Dec 31, 2015 | 6.25 Bn |
| Sep 30, 2015 | 3.76 Bn |
| Sep 30, 2015 | 3.76 Bn |
| Jun 30, 2015 | 3.02 Bn |
| Jun 30, 2015 | 3.02 Bn |
| Mar 31, 2015 | 5.00 Bn |
| Mar 31, 2015 | 5.00 Bn |
| Dec 31, 2014 | 12.74 Bn |
| Dec 31, 2014 | 12.74 Bn |
| Sep 30, 2014 | -5.18 Bn |
| Sep 30, 2014 | -5.18 Bn |
| Jun 30, 2014 | 8.18 Bn |
| Jun 30, 2014 | 8.18 Bn |
| Mar 31, 2014 | 957.00 Mn |
| Mar 31, 2014 | 957.00 Mn |
| Dec 31, 2013 | 14.28 Bn |
| Dec 31, 2013 | 14.28 Bn |
| Sep 30, 2013 | 905.00 Mn |
| Sep 30, 2013 | 905.00 Mn |
| Jun 30, 2013 | -2.07 Bn |
| Jun 30, 2013 | -2.07 Bn |
| Mar 31, 2013 | 6.01 Bn |
| Mar 31, 2013 | 6.01 Bn |
| Dec 31, 2012 | 16.49 Bn |
| Dec 31, 2012 | 16.49 Bn |
| Sep 30, 2012 | 461.00 Mn |
| Sep 30, 2012 | 461.00 Mn |
| Jun 30, 2012 | -4.32 Bn |
| Jun 30, 2012 | -4.32 Bn |
| Mar 31, 2012 | 4.74 Bn |
| Mar 31, 2012 | 4.74 Bn |
| Dec 31, 2011 | 2.50 Bn |
| Dec 31, 2011 | 2.50 Bn |
| Sep 30, 2011 | 4.35 Bn |
| Sep 30, 2011 | 4.35 Bn |
| Jun 30, 2011 | 13.80 Bn |
| Jun 30, 2011 | 13.80 Bn |
| Mar 31, 2011 | 224.00 Mn |
| Mar 31, 2011 | 224.00 Mn |
| Dec 31, 2010 | -7.36 Bn |
| Dec 31, 2010 | -7.36 Bn |
| Sep 30, 2010 | 7.71 Bn |
| Sep 30, 2010 | 7.71 Bn |
| Jun 30, 2010 | 149.00 Mn |
| Jun 30, 2010 | 149.00 Mn |
| Mar 31, 2010 | 141.00 Mn |
| Mar 31, 2010 | 141.00 Mn |
| Dec 31, 2009 | 103.00 Mn |
| Dec 31, 2009 | 103.00 Mn |
| Sep 30, 2009 | 376.00 Mn |
| Sep 30, 2009 | 376.00 Mn |
| Jun 30, 2009 | 539.00 Mn |
| Jun 30, 2009 | 539.00 Mn |
| Mar 31, 2009 | 425.00 Mn |
| Mar 31, 2009 | 425.00 Mn |